Open Nav

Please submit your session questions in advance at

Ron Newbold

Senior Vice President, US Business Development and Alliances

Otsuka America Pharmaceutical, Inc.

Dr. Ron Newbold is Senior Vice President, US Business Development and Alliances. Ron and his group support Otsuka's efforts to remain a global powerhouse in CNS therapeutics and become a leader in nephrology, by bringing novel and innovative therapeutic solutions into Otsuka's pipeline, from scouting and evaluation to implementation and alliance management.

Ron brings to Otsuka significant experience in external partnering in the Life Sciences field from his previous activities in large Pharma as well as biotech companies. After graduating from the University of Rochester and his postdoctoral fellowship in Medicinal Chemistry at Harvard University he joined Merck, where he was responsible for Strategic Research Initiatives. Following 14 years with Merck, Ron joined Sentigen Biosciences; Celldex Therapeutics; Auspex Pharmaceuticals and most recently Pfizer, where he served as Vice President, Strategic Research Partnerships, prior to joining Otsuka.

This speaker's sessions: